Selçuk Yaylacı1, Hamad Dheir1, Kubilay İşsever1, Ahmed Bilal Genc1, Didar Şenocak1, Havva Kocayigit2, Ertugrul Guclu3, Kezban Suner2, Hasan Ekerbicer4, Mehmet Koroglu5. 1. . Sakarya University Faculty of Medicine, Department of Internal Medicine. 2. . Sakarya University Education and Research Hospital, Department of Intensive Care. 3. . Sakarya University Faculty of Medicine Department of Infectious Diseases. 4. . Sakarya University Faculty of Medicine Department of Public Health. 5. . Sakarya University Faculty of Medicine Department Medical Microbiology.
Abstract
AIM: The aim of this study is to analyze the prognostic significance of ABO and Rh blood group antigens along with various parameters in patients followed-up with the diagnosis of COVID-19. METHODS: We evaluated 397 patients who were follow-up and treated due to COVID-19 infections. The ages, genders, chronic diseases, ABO and Rh blood group antigens, admission rates to Intensive Care Units (ICU), and mortality rates of the patients were analyzed. FINDINGS: The mean age of the 397 patients with COVID-19 was 47±17 years. In the blood group analysis of the patients, A Rh-positive (A +) was the most frequently seen blood type (176 patients, 44.3%) followed by O Rh-positive (0 +) (109 patients, 27,5%); 38 patients were Rh negative (Rh -) (9,6%). 53 of the patients (13,4%) were followed in ICU and 29 patients died (7,3%). Neither mortality nor admission to ICU was seen for Rh - group. The comparison of Rh groups concerning the need for ICU admission revealed a significantly high rate of ICU admission in the Rh + group (p=0,011), while no significant relationship was found between mortality and Rh antigen (p=0,069). CONCLUSION: The most frequently seen blood type among COVID-19 patients was A +. The Rh + blood group was found in all cases who were admitted to ICU and had a death outcome. The Rh + blood group was found in a significantly high number of patients who were admitted to ICU, while no significant relationship was found between mortality and Rh blood group.
AIM: The aim of this study is to analyze the prognostic significance of ABO and Rh blood group antigens along with various parameters in patients followed-up with the diagnosis of COVID-19. METHODS: We evaluated 397 patients who were follow-up and treated due to COVID-19infections. The ages, genders, chronic diseases, ABO and Rh blood group antigens, admission rates to Intensive Care Units (ICU), and mortality rates of the patients were analyzed. FINDINGS: The mean age of the 397 patients with COVID-19 was 47±17 years. In the blood group analysis of the patients, A Rh-positive (A +) was the most frequently seen blood type (176 patients, 44.3%) followed by O Rh-positive (0 +) (109 patients, 27,5%); 38 patients were Rh negative (Rh -) (9,6%). 53 of the patients (13,4%) were followed in ICU and 29 patientsdied (7,3%). Neither mortality nor admission to ICU was seen for Rh - group. The comparison of Rh groups concerning the need for ICU admission revealed a significantly high rate of ICU admission in the Rh + group (p=0,011), while no significant relationship was found between mortality and Rh antigen (p=0,069). CONCLUSION: The most frequently seen blood type among COVID-19patients was A +. The Rh + blood group was found in all cases who were admitted to ICU and had a death outcome. The Rh + blood group was found in a significantly high number of patients who were admitted to ICU, while no significant relationship was found between mortality and Rh blood group.
Authors: Carlos Jericó; Saioa Zalba-Marcos; Manuel Quintana-Díaz; Olga López-Villar; Iván Santolalla-Arnedo; Ane Abad-Motos; María Jesús Laso-Morales; Esther Sancho; Maricel Subirà; Eva Bassas; Regina Ruiz de Viñaspre-Hernández; Raúl Juárez-Vela; José Antonio García-Erce Journal: J Clin Med Date: 2022-05-28 Impact factor: 4.964
Authors: Saeed M Kabrah; Samer S Abuzerr; Mohammed A Baghdadi; Ahmed M Kabrah; Arwa F Flemban; Fayez S Bahwerth; Hamza M Assaggaf; Eisa A Alanazi; Abdullah A Alhifany; Sarah A Al-Shareef; Wesam H Alsabban; Anmar A Khan; Hissah Alzhrani; Layal K Jambi; Radi T Alsafi; Akhmed Aslam; Hebah M Kabrah; Ahmad O Babalghith; Amr J Halawani Journal: Medicine (Baltimore) Date: 2021-12-30 Impact factor: 1.889
Authors: Vanessa Lôbo de Carvalho; Deivson Cavalcante Gomes de Oliveira; Marcelo Oliveira Silva; Joana Darc Gomes de Oliveira; Leandro Eugênio Ferreira da Silva Journal: Rev Bras Med Trab Date: 2022-03-30